Immunity after yellow fever vaccination in travelers using immunosuppressive medication-YETI study

Immunity after yellow fever vaccination in travelers using immunosuppressive medication-YETI study - YETI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37037

Enrollment

Registered

2012-07-10

Start date

2012-08-06

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Yellow Fever infection

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: > 18 years Having been administered a Yellow Fever vaccination

Exclusion criteria

Exclusion criteria: 20 years prior

Design outcomes

Primary

Measure	Time frame
The number of yellow fever specific CD8+ T cells in peripheral blood mononuclear cells (PBMCs)	—

Secondary

Measure	Time frame
Height and duration of antibody presence using the plaque reduction neutralization test; Rate of local and systemic adverse events	—

Countries

Netherlands

Outcome results